REVIEW OF MAJOR INTERVENTION STUDIES IN HYPERTENSION AND HYPERLIPIDEMIA - FOCUS ON CORONARY HEART-DISEASE

被引：24
作者：
MIDDEKE, M
HOLZGREVE, H
机构：
来源：
AMERICAN HEART JOURNAL | 1988年 / 116卷 / 06期
关键词：
D O I：
10.1016/0002-8703(88)90219-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1708 / 1712
页数：5
相关论文
共 27 条
[1]  
AMERY A, 1985, LANCET, V1, P1349
[2]  
[Anonymous], 1985, J Hypertens, V3, P379
[3]  
[Anonymous], 1980, LANCET, V1, P1261
[4]  
BERGLUND G, 1978, LANCET, V1, P1
[5]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[6]   SERUM-LIPID CHANGES IN A ONE-YEAR, MULTICENTER, DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL FOR MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
FRICK, MH ;
COX, DA ;
HIMANEN, P ;
HUTTUNEN, M ;
PITKAJARVI, T ;
PORSTI, P ;
POYHONEN, L ;
PYYKONEN, ML ;
REINKAINEN, P ;
SALMELA, P ;
SARASTE, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (14) :G61-G67
[7]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[8]  
GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97
[9]   TREATMENT OF MILD HYPERTENSION - A 5-YEAR CONTROLLED DRUG TRIAL - THE OSLO STUDY [J].
HELGELAND, A .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (05) :725-732
[10]  
HOLZGREVE H, 1986, PRIMARY HYPERTENSION, P163
123